8TRD

mGluR3 class 1 in the presence of the antagonist LY 341495

  • Classification: MEMBRANE PROTEIN
  • Organism(s): Rattus norvegicus
  • Expression System: Homo sapiens
  • Mutation(s): No 
  • Membrane Protein: Yes  PDBTMmpstruc

  • Deposited: 2023-08-09 Released: 2024-07-31 
  • Deposition Author(s): Strauss, A., Levitz, J.
  • Funding Organization(s): National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS), National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.40 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization.

Strauss, A.Gonzalez-Hernandez, A.J.Lee, J.Abreu, N.Selvakumar, P.Salas-Estrada, L.Kristt, M.Arefin, A.Huynh, K.Marx, D.C.Gilliland, K.Melancon, B.J.Filizola, M.Meyerson, J.Levitz, J.

(2024) Nat Commun 15: 6498-6498

  • DOI: https://doi.org/10.1038/s41467-024-50548-x
  • Primary Citation of Related Structures:  
    8TRD

  • PubMed Abstract: 

    The metabotropic glutamate receptors (mGluRs) are neuromodulatory family C G protein coupled receptors which assemble as dimers and allosterically couple extracellular ligand binding domains (LBDs) to transmembrane domains (TMDs) to drive intracellular signaling. Pharmacologically, mGluRs can be targeted at the LBDs by glutamate and synthetic orthosteric compounds or at the TMDs by allosteric modulators. Despite the potential of allosteric compounds as therapeutics, an understanding of the functional and structural basis of their effects is limited. Here we use multiple approaches to dissect the functional and structural effects of orthosteric versus allosteric ligands. We find, using electrophysiological and live cell imaging assays, that both agonists and positive allosteric modulators (PAMs) can drive activation and internalization of group II and III mGluRs. The effects of PAMs are pleiotropic, boosting the maximal response to orthosteric agonists and serving independently as internalization-biased agonists across mGluR subtypes. Motivated by this and intersubunit FRET analyses, we determine cryo-electron microscopy structures of mGluR3 in the presence of either an agonist or antagonist alone or in combination with a PAM. These structures reveal PAM-driven re-shaping of intra- and inter-subunit conformations and provide evidence for a rolling TMD dimer interface activation pathway that controls G protein and beta-arrestin coupling.


  • Organizational Affiliation

    Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Metabotropic glutamate receptor 3
A, B
921Rattus norvegicusMutation(s): 0 
Gene Names: Grm3
Membrane Entity: Yes 
UniProt
Find proteins for P31422 (Rattus norvegicus)
Explore P31422 
Go to UniProtKB:  P31422
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP31422
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
Z99 (Subject of Investigation/LOI)
Query on Z99

Download Ideal Coordinates CCD File 
C [auth A],
D [auth B]
2-[(1S,2S)-2-carboxycyclopropyl]-3-(9H-xanthen-9-yl)-D-alanine
C20 H19 N O5
VLZBRVJVCCNPRJ-KPHUOKFYSA-N
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.40 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX1.21_5207

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States1F31NS129320
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesF32GM148001
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR01NS129904

Revision History  (Full details and data files)

  • Version 1.0: 2024-07-31
    Type: Initial release
  • Version 1.1: 2024-08-14
    Changes: Data collection, Database references